TAM LAM: Open Payments
NPI 1750752952 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 16 payments from 9 companies in 2025. Trend: 2023 $150 · 2024 $419 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $86 |
| Astellas Pharma US Inc | 3 | $74 |
| Deciphera Pharmaceuticals Inc. | 2 | $55 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| Exelixis Inc. | 1 | $20 |
Products named: XTANDI, QINLOCK, Vyloy, KEYTRUDA, OPDIVO, LIBTAYO, INLYTA, XPOVIO.
Industry payments across TX — which companies pay providers there.
